Webinar
State of the Nation: Interrogating the Benefits and Obstacles to Digitization and AI Adoption
On-demand
Join expert panelists as we dive into results of a recent Owkin survey aimed at taking the temperature of pathologists and oncologists on the state of the field of pathology in the US, UK and France. Our round table guests, hailing from the polled regions, will investigate such topics as pathologist and clinician mental health in the current landscape, diagnostic burden, barriers to implementing digital and AI solutions, navigating regulatory and healthcare systems, and insights from adopting AI solutions in pathology workflows.
Webinar Learning Objectives
- Do burnout and stress have consequences beyond pathologist and clinician relationship to their occupation?
- How are different regions responding to barriers stemming from technical integration and funding?
- Are there key insights to be gained from sharing success stories across borders?
Catherine Guettier MD, PhD
Professor Guettier is an Emeritus Professor of Pathology at Paris-Saclay University where her areas of expertise include liver, pediatric, and transplantation pathology. For 30 years she has held various leadership roles in Departments of Pathology at Assistance Publique-Hôpitaux de Paris (AP-HP). Her work there has included piloting the implementation of digital pathology and AI tools in routine pathology workflows. Professor Guettier has also served as a Research Investigator at INSERM U1193 since 2006. Most recently, she was a leading expert on France Biotech’s task force for Digital Anatomopathology.
Sheeba Irshad MD, PhD
Dr. Irshad is a clinician-scientist and practicing breast Medical Oncologist trained in tumour immunology. She is currently a clinical reader at King’s College London and has established an independent group focused on understanding the immune landscape of chemotherapy resistant breast cancers. She has led multidisciplinary laboratory/clinical teams addressing biomarker and therapy development in high-risk breast cancer leading to senior author publications in Cancer Cell, Lancet Oncology, and Clinical Cancer Research. She is also the Deputy Director in KCL/ICR Integrated Breast Cancer Now Programme, directing the KCL Research Unit and its breast cancer immunobiology focussed programme. She is also part of an international team that have recently been awarded the 2024 CRUK Grand Challenge which aims to investigate Societal, Ancestry, Molecular and Biological Analyses of Inequalities (SAMBAI).
Anthony M. Magliocco MD, FRCPC, FCAP
Dr. Magliocco is a board-certified Pathologist and Professor of Oncology and Pathology with over 30 years of experience in tissue pathology, medical research, molecular diagnostics, liquid biopsy, genetics, clinical trials, and digital image analysis. He has founded and led multiple laboratories, including Protean BioDiagnostics, and has overseen the deployment of numerous new laboratory tests in his career in both Canada and the USA. He has published over 200 research articles, has numerous patents applied, and is a frequent invited speaker to international diagnostic technology meetings. In his research he has developed new digital image analysis methods and has created numerous new diagnostic tests for use in better selecting treatment plans for patients with breast, ovary, lung, bladder and many other cancers as well as developed the unique Protean MAPS™ system. Protean MAPS™ is currently the only comprehensive precision medicine system aimed at supporting community-based cancer patients and their doctors.